Новости | Магазин | Журналы | Контакты | Правила | Доставка | |
Вход Регистрация |
Представлено описание редкого клинического наблюдения ВИПомы поджелудочной железы. Приведен обзор литературы, показаны трудности дооперационной диагностики, а также эффективность оперативного лечения.
Ключевые слова:
поджелудочная железа, нейроэндокринная опухоль, резекция, ВИПома, pancreas, neuroendocrine tumor, resection, VIPoma
Литература:
1.Falconi M., Eriksson B., Kaltsas G., Bartsch D.K., Capdevila J., Caplin M., Kos-Kudla B., Kwekkeboom D., Rindi G., Kloppel G., Reed N., Kianmanesh R., Jensen R.T. ENETS Consensus Guidelines Update for the management of patients with functional pancreatic neuroendocrine tumors and nonfunctional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016; 103 (2): 153-171. PMID: 6742109. https://doi.org/10.1159/000443171.
2.Soga J., Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reporied cases. J. Clin. Cancer Res. 1998; 17 (4): 389-400. PMID: 10089056.
3.Kikuchi K., Wada R., Sakihara S., Suda T., Yaqihashi S. Pheochromocytoma with histologic transformation to composite type, complicated by watery diarrhea, hypokalemia, and achlorhydria syndrome. Endocr. Pract. 2012; 18 (4): 91-96. PMID: 22440998. https://doi.org/10.4158/EP11370.CR.
4.Verner J.V., Morrison A.B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am. J. Med. 1958; 25 (3): 374-380. PMID: 13571250. https://doi.org/10.1016/0002-9343(58)90075-5.
5.Jensen R.T., Cadiot G., Brandi M.L., de Herder W.W., Kaltsas G., Komminoth P., Scoazec J.Y., Salazar R., Sauvanet A., Kianmanesh R. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012; 95 (2): 98-119. PMID: 22261919. https://doi.org/10.1159/000335591.
6.Dimitriadis G.K., Weickert M.O., Randeva H.S., Kaltsas G., Grossman A. Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours. Endocr. Relat. Cancer. 2016; 23 (9): 423-436. PMID: 27461388. https://doi.org/10.1530/ERC-16-0200.
7.Rindi G., Falconi M., Klersy C., Albarello L., Boninsegna L., Buchler M.W., Capella C., Caplin M., Couvelard A., Doglioni C., Delle Fave G., Fischer L., Fusai G., de Herder W.W., Jann H., Komminoth P., de Krijger R.R., La Rosa S., Luong T.V., Pape U., Perren A., Ruszniewski P., Scarpa A., Schmitt A., Solcia E., Wiedenmann B. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J. Natl. Cancer Inst. 2012; 104 (10): 764-777. PMID: 22525418. https://doi.org/10.1093/jnci/djs208.
8.Ghaferi A.A., Chojnacki K.A., Long W.D., Cameron J.L., Yeo C.J. Pancreatic VIPomas: subject review and one institutional experience. J. Gastrointest. Surg. 2008; 12 (2): 382-393. PMID: 17510774. https://doi.org/10.1007/s11605-007-0177-0.
9.Sundin A., Rockall A. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead. Neuroendocrinology. 2012; 96 (4): 261-271. PMID: 22907438. https://doi.org/10.1159/000342270.
10.Krausz Y., Freedman N., Rubinstein R., Lavie E., Orevi M., Tshori S., Salmon A., Glaser B., Chisin R., Mishani E., Gross D. 68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with 111In-DTPA-octreotide (OctreoScan®). Mol. Imaging Biol. 2011; 13 (3): 583-593. PMID: 20652423. https://doi.org/10.1007/s11307-010-0374-1.
11.Solcia E., Capella C., Kloppel G. Tumors of the pancreas. In: AFIP atlas of tumor pathology. Series 3, Fascicle 20. Washington DC: American Registry of Pathology Press, 1997: 145-209.
12.Uccella S., Sessa F., Rosa S.L. Diagnostic approach to neuroendocrine neoplasms of the gastrointestinal tract and pancreas. Turkish J. Pathol. 2015; 31 (Suppl): 113-127. PMID: 26177322. https://doi.org/10.5146/tjpath.2015.01319.
13.Araujo P.B., Cheng S., Mete O., Serra S., Morin E., Asa S.L., Ezzat S. Evaluation of the WHO 2010 Grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors. PLoS One. 2013; 8 (4): 1-9. e61538. doi: 10.1371/journal.pone.0061538.
14.Solcia E., Capella C., Riva C., Rindi G., Polak J.M. The morpho logy and neuroendocrine profile of pancreatic epithelial VIPomas and extrapancreatic, VIP-producing, neurogenic tumors. Ann. N. Y. Acad. Sci. 1988; 527 (1): 508-517. PMID: 2839087. https://doi.org/10.1111/j.1749-6632.1988.tb27004.x.
15.Papotti M., Bongiovanni M., Volante M., Allia E., Landolfi S., Helboe L., Schindler M., Cole S.L., Bussolati G. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch. 2002; 440 (5): 461-475. PMID: 12021920. https://doi.org/10.1007/s00428-002-0609-x.
16.Reubi J.C., Heitz P.U., Gyr K. Vasoactive intestinal peptide producing tumor contains high density of somatostatin receptors. Lancet. 1987; 28 (1): 741-742. PMID: 2882148. https://doi.org/10.1016/S0140-6736(87)90375-8.
17.Strosberg J.R., Cheema A., Weber J., Han G., Coppola D., Kvols L.K. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J. Clin. Oncol. 2011; 29 (22): 3044-3049. PMID: 21709192. https://doi.org/10.1200/JCO.2011.35.1817.
18.Anderson C.W., Bennett J.J. Clinical presentation and diagnosis of pancreatic neuroendocrine tumors. Surg. Oncol. Clin. N. Am. 2016; 25 (2): 363-364. PMID: 27013370. https://doi.org/10.1016/j.soc.2015.12.003.
19.Cavalli T., Giudici F., Santi R., Nesi G., Brandi M.L., Tonelli F. Ventricular fibrillation resulting from electrolyte imbalance reveals VIPoma in MEN1 syndrome. Fam. Cancer. 2016; 15 (4): 645-649. PMID: 27071757. https://doi.org/10.1007/s10689-016-9906-4.
20.Martin R.C. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma. J. Gastrointest. Surg. 2013; 17 (10): 1850-1856. PMID: 23929188. https://doi.org/10.1007/s11605-013-2309-z.
21.Martin R.C. 2nd, McFarland K., Ellis S., Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann. Surg. Oncol. 2013; 20 (Suppl 3): 443-449. PMID: 23128941. https://doi.org/10.1245/s10434-012-2736-1.
A description of a rare clinical observation of pancreatic VIPoma is presented. Submitted literature review. The difficulties of preoperative diagnosis, as well as the effectiveness of surgical treatment are shown.
Keywords:
поджелудочная железа, нейроэндокринная опухоль, резекция, ВИПома, pancreas, neuroendocrine tumor, resection, VIPoma